Both in Pharmaceuticals
Citius Oncology vs RenovoRx
Over the past year CTOR returned −68.0% and RNXT returned +31.0%; their daily moves had a correlation of 0.14.
CTOR −68.0% RNXT +31.0%Growth of $1, one year, split-adjusted
| Metric | CTOR | RNXT |
|---|---|---|
| Price | $0.5540 | $1.33 |
| Market cap | $58.6M | $60.0M |
| Today | +4.63% | −10.74% |
| 1 month | −43.5% | −14.2% |
| 6 months | −41.4% | +50.6% |
| Year to date | −44.6% | +58.3% |
| 1 year | −68.3% | +26.7% |
| Revenue growth (YoY) | — | +115.4% |
| Gross margin | 67.1% | 84.3% |
| Net margin | −597.4% | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | 30.4× |
| Net cash | $10.2M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | 108.0% |
| Short % of float | 0.8% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).